Literature DB >> 17610264

Exercise echocardiography reveals subclinical cardiac dysfunction in young adult survivors of childhood acute lymphoblastic leukemia.

M Jarfelt1, V Kujacic, D Holmgren, R Bjarnason, B Lannering.   

Abstract

OBJECTIVE: Anthracyclines (AC) have contributed significantly to increased survival rate in acute lymphoblastic leukemia (ALL), although the use of these drugs is limited due to cardiotoxicity. The aim was to evaluate heart muscle function in asymptomatic adult survivors of ALL treated in early childhood in relation to the combined effects of AC and other potential cardiotoxic factors. PROCEDURE: Twenty-three young adult ALL survivors who had all received treatment with median 120 (120-400) mg AC/m(2) before the onset of puberty were examined median 21 years after remission and compared with 12 healthy controls. Basal echocardiography including two-dimensional (2D) M-mode and Doppler examination was performed, followed by a maximal exercise stress test and stress echocardiography immediately after stress test and after 5 min recovery.
RESULTS: We found significant differences in systolic function between patients and controls at maximal exercise despite absence of reported symptoms from the patients. The most marked difference was in ejection fraction at stress 59.5% (32.6-81.1) and 77.3% (66.2-85.3), respectively (P < 0.00006). Ten out of 23 patients reduced their ejection fraction at stress compared with at rest; this was not found in any of the controls. Cardiovascular risk factors such as GH deficiency and a high proportion of trunk fat did not have an impact on cardiac function.
CONCLUSIONS: With very long follow up in a homogenous cohort of ALL survivors, we found subclinical cardiac dysfunction with exercise stress echocardiography even after low doses of AC. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610264     DOI: 10.1002/pbc.21289

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  20 in total

1.  Advanced Echocardiographic Techniques in Detection of Cardiotoxicity.

Authors:  Aarti A Patel; Arthur J Labovitz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-04

2.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A Sebag; Deborah A Agler; Luigi P Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M DeCara; Thor Edvardsen; Scott D Flamm; Thomas Force; Brian P Griffin; Guy Jerusalem; Jennifer E Liu; Andreia Magalhães; Thomas Marwick; Liza Y Sanchez; Rosa Sicari; Hector R Villarraga; Patrizio Lancellotti
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-10       Impact factor: 6.875

3.  Physical fitness in children infected with the human immunodeficiency virus: associations with highly active antiretroviral therapy.

Authors:  Gabriel Somarriba; Gabriela Lopez-Mitnik; David A Ludwig; Daniela Neri; Natasha Schaefer; Steven E Lipshultz; Gwendolyn B Scott; Tracie L Miller
Journal:  AIDS Res Hum Retroviruses       Date:  2012-07-31       Impact factor: 2.205

4.  Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial.

Authors:  Jeffrey E Rubnitz; Norman J Lacayo; Hiroto Inaba; Kenneth Heym; Raul C Ribeiro; Jeffrey Taub; Jennifer McNeer; Barbara Degar; Deborah Schiff; Allen Eng-Juh Yeoh; Elaine Coustan-Smith; Lei Wang; Brandon Triplett; Susana C Raimondi; Jeffery Klco; John Choi; Stanley Pounds; Ching-Hon Pui
Journal:  J Clin Oncol       Date:  2019-06-27       Impact factor: 44.544

5.  Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography.

Authors:  Timothy C Tan; Marielle Scherrer-Crosbie
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-12-01

Review 6.  Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?

Authors:  Timothy M Markman; Maurie Markman
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

7.  The prevention of cardiovascular disease in cancer survivors.

Authors:  Iyad N Daher; Tina R Daigle; Nirmanmoh Bhatia; Jean-Bernard Durand
Journal:  Tex Heart Inst J       Date:  2012

8.  Is there a role for complementary therapy in the management of leukemia?

Authors:  Kathleen M Wesa; Barrie R Cassileth
Journal:  Expert Rev Anticancer Ther       Date:  2009-09       Impact factor: 4.512

9.  Cardiac complications of chemotherapy: role of imaging.

Authors:  Timothy C Tan; Marielle Scherrer-Crosbie
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-04

Review 10.  Evaluation and management of patients with heart disease and cancer: cardio-oncology.

Authors:  Joerg Herrmann; Amir Lerman; Nicole P Sandhu; Hector R Villarraga; Sharon L Mulvagh; Manish Kohli
Journal:  Mayo Clin Proc       Date:  2014-09       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.